BCL2L1 and cancer: In cancer, several oncogenes and tumour promoters are translationally controlled by hnRNPA1, including cMYC, Cyclin D1, FGF-2, XIAP (10,17,49) and BCL-XL (this report), all of which possess IRESs in their mRNAs.